Literature DB >> 20686438

Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit.

Jesús Oteo1, José Luis Hernández-Almaraz, Javier Gil-Antón, Ana Vindel, Sara Fernández, Verónica Bautista, José Campos.   

Abstract

Pediatric patients are rarely infected with metallo-β-lactamase-producing Enterobacteriaceae. We describe 3 cases of children infected with VIM-1-producing clonal Enterobacter cloacae. Patients were treated with amikacin and cotrimoxazole. The blaVIM-1 gene was carried into a class 1 integron and an IncHI2 incompatibility group plasmid. Emergence of pediatric infections caused by carbapenemases-producing Enterobacteriaceae is a critical issue as they are resistant to most β-lactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686438     DOI: 10.1097/INF.0b013e3181efaa2d

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

Authors:  Isabel Sánchez-Romero; Angel Asensio; Jesús Oteo; María Muñoz-Algarra; Beatriz Isidoro; Ana Vindel; José Alvarez-Avello; Bárbara Balandín-Moreno; Oscar Cuevas; Sara Fernández-Romero; Luisa Azañedo; David Sáez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.

Authors:  E Miró; J Agüero; M N Larrosa; A Fernández; M C Conejo; G Bou; J J González-López; N Lara; L Martínez-Martínez; A Oliver; B Aracil; J Oteo; A Pascual; J Rodríguez-Baño; L Zamorano; F Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-07       Impact factor: 3.267

3.  Clonal Dissemination of Enterobacter cloacae Harboring blaKPC-3 in the Upper Midwestern United States.

Authors:  Melissa L Hargreaves; Kristin M Shaw; Ginette Dobbins; Paula M Snippes Vagnone; Jane E Harper; Dave Boxrud; Ruth Lynfield; Maliha Aziz; Lance B Price; Kevin A T Silverstein; Jessica L Danzeisen; Bonnie Youmans; Kyle Case; Srinand Sreevatsan; Timothy J Johnson
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

4.  Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Authors:  Kathleen Chiotos; Jennifer H Han; Pranita D Tamma
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

5.  [Current detection rates of multiresistant gram negative bacteria (3MRGN, 4MRGN) in patients with chronic leg ulcers].

Authors:  F Jockenhöfer; H Gollnick; K Herberger; G Isbary; R Renner; M Stücker; E Valesky; U Wollina; M Weichenthal; S Karrer; B Ross; E Heintschel von Heinegg; J Dissemond
Journal:  Hautarzt       Date:  2014-11       Impact factor: 0.751

6.  Carbapenemase-producing enterobacteriaceae in Spain in 2012.

Authors:  Jesús Oteo; David Saez; Verónica Bautista; Sara Fernández-Romero; Juan Manuel Hernández-Molina; María Pérez-Vázquez; Belén Aracil; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

Review 7.  Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.

Authors:  Constance Schultsz; Suzanne Geerlings
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

8.  CTX-M Enzymes: Origin and Diffusion.

Authors:  Rafael Cantón; José María González-Alba; Juan Carlos Galán
Journal:  Front Microbiol       Date:  2012-04-02       Impact factor: 5.640

9.  First Italian outbreak of VIM-producing Serratia marcescens in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review.

Authors:  Maria Rosaria Iovene; Vincenzo Pota; Massimiliano Galdiero; Giusy Corvino; Federica Maria Di Lella; Debora Stelitano; Maria Beatrice Passavanti; Maria Caterina Pace; Aniello Alfieri; Sveva Di Franco; Caterina Aurilio; Pasquale Sansone; Vettakkara Kandy Muhammed Niyas; Marco Fiore
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.